Trust Is the Real Question
Can AI outputs be trusted? This is one of the most important questions healthcare professionals ask about generative AI. This question is especially important in medical information and medical writing because the value of a response depends on clarity and whether every statement is grounded in verifiable evidence and can withstand expert scrutiny. This matters because these workflows impact clinical judgment, scientific exchange, and regulated healthcare communication.
Where AI Is Gaining Ground
For clinicians, medical information often means finding and interpreting evidence for care decisions by reviewing literature, checking treatment guidelines, or synthesizing information from multiple sources to support a treatment decision. For pharmaceutical medical information teams, it means developing accurate, balanced, and traceable scientific responses that shape how healthcare professionals interpret data. Medical writing determines how evidence is summarized, contextualized, and communicated across research, scientific exchange, and regulated environments.
Generative AI is naturally attractive in all of these settings because the work is text-heavy, labor-intensive, time-consuming, and expensive to scale efficiently. AI solutions can speed literature discovery, create drafts, and help professionals move through medical communication workflows faster.
However, those benefits come with a meaningful risk of AI hallucinations that can affect how scientific information is consumed, influence care-related decisions, and contribute to misinformation if left unchecked.
The Clinician’s AI Trust Problem
For clinicians, the question is whether AI helps clarify evidence or makes uncertainty seem factual. Clinicians are asked to trust an output that cannot be properly reviewed if an AI system offers a concise summary, but the source of the conclusion is unclear. In a clinical decision workflow, that is not efficiency. It is hidden risk.
Clinicians need a system that helps them quickly find trusted evidence and shows where the information came from.
The Medical Information and Medical Writing AI Dilemma
The challenge is equally serious for pharmaceutical medical information teams and medical writers. These teams operate in highly regulated environments where accuracy, balance, and traceability are nonnegotiable.
AI can help by accelerating literature review, surfacing relevant evidence, and producing first drafts. But if a model confuses findings from different studies, overstates conclusions, omits context, or invents supporting references, the output becomes less useful and potentially risky.
The Solution Starts With System Design
Hallucinations do not make AI unusable. They make system design more important. AI systems for medical and scientific workflows should be evidence-first, include a robust retrieval pipeline, use strong models, and provide built-in source traceability so users can see exactly where statements came from. They should encourage users to point the platform to credible, vetted resources rather than relying on the model’s general training knowledge.
These systems should make review easier and help users inspect source material, edit outputs, recognize when a response is not based on evidence, and clearly say if credible source material is missing. The model should be able to respond plainly: I do not know, or I do not have enough information to answer credibly.
That kind of restraint and transparency is a strength, not a weakness of the AI platform.
Workflow Design Still Requires Human Expertise
Technology alone is not enough. Safe and effective AI use also depends on workflow design. Human responsibility includes defining the task, deciding whether AI should be used, selecting the right platform, setting guardrails, identifying credible knowledge sources, giving clear instructions, and reviewing and revising outputs. AI outputs should be treated as drafts, not final work, until a qualified human has reviewed them and accepted responsibility.
This is the difference between using AI as an automated shortcut and using it as a managed productivity tool.
User Training, Practice, and Expectations Matter
User training, practice, and a willingness to experiment with AI solutions are essential. Many users may feel that the cognitive load of learning a new system may not be worth the effort, especially if they have to review the outputs. As users become more familiar with a platform, the effort required to use it effectively decreases, while the productivity gain increases significantly.
There is a common assumption that reviewing AI outputs and refining them over several prompts eliminates the time savings. That comparison and conclusion are not logical. A human-written draft that takes days to prepare and still contains gaps or errors typically goes through multiple rounds of review before it is final. If an AI solution can help users find relevant literature in seconds and produce a workable draft in seconds, and the user then spends minutes reviewing and refining it, the net efficiency gain is still substantial.
Users should have realistic expectations about what AI solutions are capable of. One common mistake is assuming that AI models can function as experts in every domain. Trained professionals remain the experts, and the AI platform is a tool that supports them.
Successful use of AI in medical information, medical writing, and clinical workflows depends on the platform and users who understand its capabilities, limits, and assume responsibility for using it appropriately.
What Leaders Should Prioritize
The approach should be straightforward for decision-makers. Organizations should not evaluate AI for medical information, medical writing, or clinical workflows based primarily on speed, popularity, or ambitious claims. They should prioritize systems that are:
- Evidence-grounded
- Transparent
- Auditable
- Built for the specific workflow
- Designed to support human review
The system is only part of the equation. Leaders must equip users with the right training, provide support, set realistic expectations, establish governance, and ensure accountability for AI-supported work.
Trust Must Be Designed, Not Assumed
Hallucinations are not a reason to avoid AI in medical information and medical writing. When the right platform is paired with the right workflow, hallucinations can be minimized and caught before they affect the final output. The best approach is not blind trust in AI, and not blanket rejection of it, but trust built on evidence-first system design, governance, effective workflows, and human oversight and accountability.
About Ome Ogbru, PharmD
Ome Ogbru, PharmD, is the CEO and Founder of AINGENS, a life sciences software company building evidence-first AI platforms for scientific and medical workflows. With over 20 years of experience across pharma, biotech, and healthcare, his background includes roles as a clinical pharmacist, professor, and global medical information leader, where he worked at the intersection of science, regulation, and content creation.
Driven by firsthand experience with the inefficiencies of evidence-based content workflows, Dr. Ogbru founded AINGENS to develop practical, enterprise-ready solutions that improve how scientific information is created, reviewed, and delivered. Through its flagship platform, MACg (Medical Affairs Content Generator), he focuses on enabling faster, more reliable medical and scientific communication without compromising accuracy or compliance.
